Skip to main content
. 2023 Nov 9;14:1288883. doi: 10.3389/fphar.2023.1288883

FIGURE 5.

FIGURE 5

Myricetin inhibits TGF-β-induced migration and invasion in ovarian cancer cells. (A) Representative results of wound healing assays. The bar chart represents the migration distance. Error bars represent the means ± SD of three independent experiments (5 fields/experiment).(B) Changes in A2780 and HO8910 cells migration and invasion after treatment with TGF-β alone or in combination with myricetin by transwell assay.*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 were considered statistically significant, n = 3.